97 related articles for article (PubMed ID: 22306122)
1. The discovery of aminopyrazines as novel, potent Na(v)1.7 antagonists: hit-to-lead identification and SAR.
Bregman H; Nguyen HN; Feric E; Ligutti J; Liu D; McDermott JS; Wilenkin B; Zou A; Huang L; Li X; McDonough SI; Dimauro EF
Bioorg Med Chem Lett; 2012 Mar; 22(5):2033-42. PubMed ID: 22306122
[TBL] [Abstract][Full Text] [Related]
2. Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists.
Chakka N; Bregman H; Du B; Nguyen HN; Buchanan JL; Feric E; Ligutti J; Liu D; McDermott JS; Zou A; McDonough SI; Dimauro EF
Bioorg Med Chem Lett; 2012 Mar; 22(5):2052-62. PubMed ID: 22318156
[TBL] [Abstract][Full Text] [Related]
3. Discovery and biological evaluation of potent, selective, orally bioavailable, pyrazine-based blockers of the Na(v)1.8 sodium channel with efficacy in a model of neuropathic pain.
Scanio MJ; Shi L; Drizin I; Gregg RJ; Atkinson RN; Thomas JB; Johnson MS; Chapman ML; Liu D; Krambis MJ; Liu Y; Shieh CC; Zhang X; Simler GH; Joshi S; Honore P; Marsh KC; Knox A; Werness S; Antonio B; Krafte DS; Jarvis MF; Faltynek CR; Marron BE; Kort ME
Bioorg Med Chem; 2010 Nov; 18(22):7816-25. PubMed ID: 20965738
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of 1,2-trans-(1-hydroxy-3-phenylprop-1-yl)cyclopentane carboxamide derivatives, a new class of sodium channel blockers.
Ok D; Li C; Abbadie C; Felix JP; Fisher MH; Garcia ML; Kaczorowski GJ; Lyons KA; Martin WJ; Priest BT; Smith MM; Williams BS; Wyvratt MJ; Parsons WH
Bioorg Med Chem Lett; 2006 Mar; 16(5):1358-61. PubMed ID: 16337121
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 2: α-Branched quaternary amines.
Hunt T; Atherton-Watson HC; Collingwood SP; Coote KJ; Czarnecki S; Danahay H; Howsham C; Hunt P; Paisley D; Young A
Bioorg Med Chem Lett; 2012 Apr; 22(8):2877-9. PubMed ID: 22425452
[TBL] [Abstract][Full Text] [Related]
6. A-887826 is a structurally novel, potent and voltage-dependent Na(v)1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats.
Zhang XF; Shieh CC; Chapman ML; Matulenko MA; Hakeem AH; Atkinson RN; Kort ME; Marron BE; Joshi S; Honore P; Faltynek CR; Krafte DS; Jarvis MF
Neuropharmacology; 2010 Sep; 59(3):201-7. PubMed ID: 20566409
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel class of benzazepinone Na(v)1.7 blockers: potential treatments for neuropathic pain.
Hoyt SB; London C; Gorin D; Wyvratt MJ; Fisher MH; Abbadie C; Felix JP; Garcia ML; Li X; Lyons KA; McGowan E; MacIntyre DE; Martin WJ; Priest BT; Ritter A; Smith MM; Warren VA; Williams BS; Kaczorowski GJ; Parsons WH
Bioorg Med Chem Lett; 2007 Aug; 17(16):4630-4. PubMed ID: 17588748
[TBL] [Abstract][Full Text] [Related]
8. Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic pain.
Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Thomas JB; Johnson MS; Carroll WA; Marron BE; Chapman ML; Liu D; Krambis MJ; Shieh CC; Zhang X; Hernandez G; Gauvin DM; Mikusa JP; Zhu CZ; Joshi S; Honore P; Marsh KC; Roeloffs R; Werness S; Krafte DS; Jarvis MF; Faltynek CR; Kort ME
Bioorg Med Chem; 2008 Jun; 16(12):6379-86. PubMed ID: 18501613
[TBL] [Abstract][Full Text] [Related]
9. Imidazopyridines: a novel class of hNav1.7 channel blockers.
London C; Hoyt SB; Parsons WH; Williams BS; Warren VA; Tschirret-Guth R; Smith MM; Priest BT; McGowan E; Martin WJ; Lyons KA; Li X; Karanam BV; Jochnowitz N; Garcia ML; Felix JP; Dean B; Abbadie C; Kaczorowski GJ; Duffy JL
Bioorg Med Chem Lett; 2008 Mar; 18(5):1696-701. PubMed ID: 18243692
[TBL] [Abstract][Full Text] [Related]
10. 2,4(5)-diarylimidazoles as inhibitors of hNaV1.2 sodium channels: pharmacological evaluation and structure-property relationships.
Fantini M; Rivara M; Zuliani V; Kalmar CL; Vacondio F; Silva C; Baheti AR; Singh N; Merrick EC; Katari RS; Cocconcelli G; Ghiron C; Patel MK
Bioorg Med Chem; 2009 May; 17(10):3642-8. PubMed ID: 19394229
[TBL] [Abstract][Full Text] [Related]
11. 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Liberatore AM; Schulz J; Pommier J; Barthelemy MA; Huchet M; Chabrier PE; Bigg D
Bioorg Med Chem Lett; 2004 Jul; 14(13):3521-3. PubMed ID: 15177465
[TBL] [Abstract][Full Text] [Related]
12. Discovery of isoxazole voltage gated sodium channel blockers for treatment of chronic pain.
Shao PP; Ye F; Weber AE; Li X; Lyons KA; Parsons WH; Garcia ML; Priest BT; Smith MM; Felix JP; Williams BS; Kaczorowski GJ; McGowan E; Abbadie C; Martin WJ; McMasters DR; Gao YD
Bioorg Med Chem Lett; 2009 Sep; 19(18):5334-8. PubMed ID: 19683443
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of skeletal analogues of saxitoxin derivatives and evaluation of their inhibitory activity on sodium ion channels Na(V)1.4 and Na(V)1.5.
Shinohara R; Akimoto T; Iwamoto O; Hirokawa T; Yotsu-Yamashita M; Yamaoka K; Nagasawa K
Chemistry; 2011 Oct; 17(43):12144-52. PubMed ID: 21922571
[TBL] [Abstract][Full Text] [Related]
14. Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivatives.
Kort ME; Atkinson RN; Thomas JB; Drizin I; Johnson MS; Secrest MA; Gregg RJ; Scanio MJ; Shi L; Hakeem AH; Matulenko MA; Chapman ML; Krambis MJ; Liu D; Shieh CC; Zhang X; Simler G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Werness S; Antonio B; Marsh KC; Faltynek CR; Krafte DS; Jarvis MF; Marron BE
Bioorg Med Chem Lett; 2010 Nov; 20(22):6812-5. PubMed ID: 20855211
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human Na(v)1.5 sodium channels by strychnine and its analogs.
Yuan C; Sun L; Zhang M; Li S; Wang X; Gao T; Zhu X
Biochem Pharmacol; 2011 Aug; 82(4):350-7. PubMed ID: 21616062
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: synthesis, SAR, and pharmacokinetic properties.
Martin MW; Newcomb J; Nunes JJ; Bemis JE; McGowan DC; White RD; Buchanan JL; DiMauro EF; Boucher C; Faust T; Hsieh F; Huang X; Lee JH; Schneider S; Turci SM; Zhu X
Bioorg Med Chem Lett; 2007 Apr; 17(8):2299-304. PubMed ID: 17276681
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel chemotype of potent human ENaC blockers using a bioisostere approach. Part 1: quaternary amines.
Hunt T; Atherton-Watson HC; Axford J; Collingwood SP; Coote KJ; Cox B; Czarnecki S; Danahay H; Devereux N; Howsham C; Hunt P; Paddock V; Paisley D; Young A
Bioorg Med Chem Lett; 2012 Jan; 22(2):929-32. PubMed ID: 22197144
[TBL] [Abstract][Full Text] [Related]
18. Structural trends among second-generation voltage-gated sodium channel blockers.
Kemp MI
Prog Med Chem; 2010; 49():81-111. PubMed ID: 20855039
[No Abstract] [Full Text] [Related]
19. Substituted biaryl pyrazoles as sodium channel blockers.
Tyagarajan S; Chakravarty PK; Zhou B; Taylor B; Fisher MH; Wyvratt MJ; Lyons K; Klatt T; Li X; Kumar S; Williams B; Felix J; Priest BT; Brochu RM; Warren V; Smith M; Garcia M; Kaczorowski GJ; Martin WJ; Abbadie C; McGowan E; Jochnowitz N; Parsons WH
Bioorg Med Chem Lett; 2010 Sep; 20(18):5480-3. PubMed ID: 20709545
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, structure-activity relationships, and in vivo evaluation of N3-phenylpyrazinones as novel corticotropin-releasing factor-1 (CRF1) receptor antagonists.
Hartz RA; Ahuja VT; Arvanitis AG; Rafalski M; Yue EW; Denhart DJ; Schmitz WD; Ditta JL; Deskus JA; Brenner AB; Hobbs FW; Payne J; Lelas S; Li YW; Molski TF; Mattson GK; Peng Y; Wong H; Grace JE; Lentz KA; Qian-Cutrone J; Zhuo X; Shu YZ; Lodge NJ; Zaczek R; Combs AP; Olson RE; Bronson JJ; Mattson RJ; Macor JE
J Med Chem; 2009 Jul; 52(14):4173-91. PubMed ID: 19552437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
